Do gut microbes affect enterohepatic recycling and availability of thyroid hormones?

The relationship between the gut microbiota and thyroid function, often termed the "thyroid-gut axis," is a critical factor in maintaining systemic hormone homeostasis. Evidence indicates that the gut serves as a significant extra-thyroidal reservoir, with approximately 20% to 60% of circulating thyroid hormones undergoing enterohepatic recycling.

Clinical and Systemic Evidence

Research suggests that the gut microbiota directly influences the bioavailability of thyroid hormones. In clinical settings, patients with small intestinal bacterial overgrowth (SIBO) or reduced microbial diversity often experience fluctuations in thyroid-stimulating hormone (TSH) and active hormone levels. Studies have demonstrated that modulating the gut environment with probiotics can lead to significant reductions in TSH and increases in free T3 and T4 levels, particularly in individuals with existing thyroid disorders. Furthermore, a substantial portion of the daily T3 requirement—estimated at up to 25%—may be met through the recycling of thyroid conjugates, a process entirely dependent on microbial activity.

Mechanistic Pathway: Microbial Deconjugation

The primary mechanism for recycling involves the deconjugation of hormone metabolites. In the liver, T4 and T3 are conjugated with glucuronic acid or sulfate to facilitate biliary excretion. Once in the intestinal lumen, microbial enzymes—specifically β-glucuronidases and sulfatases—hydrolyze these conjugates.

• Key Taxa: Species within the Bacteroides, Bifidobacterium, and Clostridium genera are the primary producers of these enzymes.
• Action: By cleaving the conjugate bonds, these microbes liberate free, lipophilic T3 and T4, allowing for their reabsorption into the portal circulation. Without this activity, these hormones would be lost via fecal excretion.

Mechanistic Pathway: Bile Acid Signaling

Gut microbes further influence thyroid signaling by modifying the bile acid pool. Microbes convert primary bile acids into secondary bile acids, such as lithocholic acid (LCA) and deoxycholic acid (DCA), which act as potent signaling molecules.

• TGR5 Activation: Secondary bile acids activate the TGR5 receptor in peripheral tissues, which triggers a cAMP-dependent pathway that induces Type 2 deiodinase (D2).
• Hormone Conversion: Increased D2 activity accelerates the conversion of T4 into active T3, thereby enhancing local and systemic thyroid signaling.

Clinical Considerations

For populations such as postmenopausal women or those on levothyroxine therapy, gut health is a primary determinant of medication stability. Dysbiosis can impair recycling efficiency, leading to higher requirements for exogenous hormones. Maintaining a diverse microbiome is essential for ensuring the consistent availability of the active hormone pool.

Bottom line

Gut microbes are essential regulators of thyroid homeostasis; they facilitate the reabsorption of up to 50% of excreted thyroid hormones through deconjugation and enhance hormone activation via bile acid-mediated signaling pathways.